Monte S. Dirks

1.3k total citations
20 papers, 975 citations indexed

About

Monte S. Dirks is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Monte S. Dirks has authored 20 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Ophthalmology, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Monte S. Dirks's work include Glaucoma and retinal disorders (13 papers), Ocular Surface and Contact Lens (5 papers) and Ophthalmology and Eye Disorders (4 papers). Monte S. Dirks is often cited by papers focused on Glaucoma and retinal disorders (13 papers), Ocular Surface and Contact Lens (5 papers) and Ophthalmology and Eye Disorders (4 papers). Monte S. Dirks collaborates with scholars based in United States, United Kingdom and Belgium. Monte S. Dirks's co-authors include Amy L. Batoosingh, Peter R Bernstein, Scott M. Whitcup, Robert Noecker, Neil T Choplin, Harvey Dubiner, Jeffrey S. Heier, Trexler M. Topping, William C. Stewart and Amanda M. VanDenburgh and has published in prestigious journals such as The Lancet, Ophthalmology and The Journal of Urology.

In The Last Decade

Monte S. Dirks

17 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monte S. Dirks United States 12 796 464 329 122 107 20 975
Harvey Dubiner United States 19 1.1k 1.4× 723 1.6× 445 1.4× 106 0.9× 151 1.4× 33 1.3k
Kathleen Fillacier France 4 415 0.5× 291 0.6× 231 0.7× 30 0.2× 31 0.3× 6 518
Amy L. Batoosingh United States 11 579 0.7× 326 0.7× 229 0.7× 52 0.4× 76 0.7× 15 619
Lucia Tanga Italy 15 606 0.8× 102 0.2× 236 0.7× 69 0.6× 43 0.4× 42 744
Kuankuan Chen United States 6 514 0.6× 253 0.5× 167 0.5× 57 0.5× 78 0.7× 6 620
Nava Naveh Israel 13 342 0.4× 69 0.1× 209 0.6× 58 0.5× 34 0.3× 40 550
J.L. Bellot Spain 10 429 0.5× 117 0.3× 321 1.0× 29 0.2× 8 0.1× 16 702
Roberto González-Salinas Mexico 14 402 0.5× 94 0.2× 251 0.8× 23 0.2× 14 0.1× 56 601
Irving M. Katz United States 8 302 0.4× 107 0.2× 88 0.3× 50 0.4× 30 0.3× 8 389
S M Podos United States 11 504 0.6× 118 0.3× 121 0.4× 83 0.7× 69 0.6× 19 613

Countries citing papers authored by Monte S. Dirks

Since Specialization
Citations

This map shows the geographic impact of Monte S. Dirks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monte S. Dirks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monte S. Dirks more than expected).

Fields of papers citing papers by Monte S. Dirks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monte S. Dirks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monte S. Dirks. The network helps show where Monte S. Dirks may publish in the future.

Co-authorship network of co-authors of Monte S. Dirks

This figure shows the co-authorship network connecting the top 25 collaborators of Monte S. Dirks. A scholar is included among the top collaborators of Monte S. Dirks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monte S. Dirks. Monte S. Dirks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johannesen, Helle Hjorth, et al.. (2017). MR scanning, tattoo inks, and risk of thermal burn: An experimental study of iron oxide and organic pigments. Skin Research and Technology. 24(2). 278–284. 14 indexed citations
2.
Sambursky, Robert, William F. Davitt, Robert Latkany, et al.. (2013). Sensitivity and Specificity of a Point-of-Care Matrix Metalloproteinase 9 Immunoassay for Diagnosing Inflammation Related to Dry Eye. JAMA Ophthalmology. 131(1). 24–24. 159 indexed citations
3.
Stalmans, Ingeborg, David Callanan, Monte S. Dirks, et al.. (2012). Treatment of Steroid-Induced Elevated Intraocular Pressure with Anecortave Acetate: A Randomized Clinical Trial. Journal of Ocular Pharmacology and Therapeutics. 28(6). 559–565. 5 indexed citations
4.
Dirks, Monte S., Robert J. Noecker, Melissa Earl, et al.. (2006). A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma. Advances in Therapy. 23(3). 385–394. 37 indexed citations
5.
Simmons, Steven T., Monte S. Dirks, & Robert J. Noecker. (2004). Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: Results from parallel-group comparison trials. Advances in Therapy. 21(4). 247–262. 39 indexed citations
6.
7.
Noecker, Robert, Monte S. Dirks, Neil T Choplin, et al.. (2003). Response to letter to the editor by Dr. Robin: Author reply. American Journal of Ophthalmology. 135(6). 922–923.
8.
Sponsel, William Eric, et al.. (2002). Comparison of the Frequency Doubling Technology screening algorithm and the Humphrey 24‐2 SITA‐FAST in a large eye screening. Clinical and Experimental Ophthalmology. 30(1). 8–14. 18 indexed citations
9.
Noecker, Robert, Monte S. Dirks, Neil T Choplin, et al.. (2002). A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. American Journal of Ophthalmology. 135(1). 55–63. 264 indexed citations
11.
Dubiner, Harvey, David L. Cooke, Monte S. Dirks, et al.. (2001). Efficacy and Safety of Bimatoprost in Patients with Elevated Intraocular Pressure. Survey of Ophthalmology. 45. S353–S360. 137 indexed citations
12.
Heier, Jeffrey S., et al.. (2000). Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology. 107(11). 2034–2038. 138 indexed citations
13.
Dirks, Monte S., et al.. (2000). A COST MINIMIZATION ANALYSIS COMPARING BRIMONIDINE TO APRACLONIDINE IN IOP CONTROL FOLLOWING ALT. Journal of Glaucoma. 9(1). 120–120. 1 indexed citations
14.
Cheetham, Janet K., Ronald E. DeGryse, Monte S. Dirks, et al.. (1999). Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery:. American Journal of Ophthalmology. 127(3). 253–259. 58 indexed citations
15.
Barnes, Scott D., et al.. (1999). Control of intraocular pressure elevations after argon laser trabeculoplasty. Ophthalmology. 106(10). 2033–2037. 25 indexed citations
16.
Teichman, Joel M.H., et al.. (1999). COLOR VISION DEFICITS AND LASER EYEWEAR PROTECTION FOR SOFT TISSUE LASER APPLICATIONS. The Journal of Urology. 874–880.
17.
Teichman, Joel M.H., et al.. (1999). COLOR VISION DEFICITS AND LASER EYEWEAR PROTECTION FOR SOFT TISSUE LASER APPLICATIONS. The Journal of Urology. 161(3). 874–880. 5 indexed citations
18.
Barnes, Scott D., et al.. (1999). CONTROL OF INTRAOCULAR PRESSURE SPIKES AFTER ARGON LASER TRABECULOPLASTY. Journal of Glaucoma. 8(Supplement 1). S15–S15. 1 indexed citations
19.
Teichman, Joel M.H., et al.. (1998). COLOR VISION DEFICITS DURING LASER LITHOTRIPSY USING SAFETY GOGGLES FOR COUMARIN GREEN OR ALEXANDRITE BUT NOT WITH HOLMIUM: YAG LASER SAFETY GOGGLES. The Journal of Urology. 159(3). 683–689. 5 indexed citations
20.
Kinnaert, P, et al.. (1969). A.L.S. AND RETICULOENDOTHELIAL BLOCKADE. The Lancet. 294(7632). 1250–1251. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026